MEDPLUS

Medplus Health Services Ltd.

NSE: MEDPLUS

BSE: 543427

Sector: Consumer Services

Industry Group: Retailing

Industry: Pharmacy Retail

816.20-2.8 (-0.34%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

81.7 / 100

Value Score

39.4 / 100

Price Momentum Score

67.8 / 100

QVM Score

74.9 / 100

Key Metrics

Market Cap

9805.58

P/E (TTM)

44.64

P/B

4.96

P/S (TTM)

1.42

EV/EBITDA

17.48

CAPE (5Y)

83.31

ROE (TTM)

11.82

ROCE (TTM)

10.37

ROA (TTM)

6.02

Avg 3Y ROE

8.38

Earnings 3Y CAGR

63.95

Sales 3Y CAGR

14.78

Sales 5Y CAGR

17.56

Debt/Equity

0.72

Consensus TP

1150.00

Strong Buy %

71.43

Promoter Holding

40.22

Pledged %

60.74

Stock Analysis

Fundamental analysis overview of Medplus Health Services Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 1.86% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

Moderate ROE but improving trend

The company reported moderate ROE of 11.82% for 12-month ended 31 Mar 2026 but ROE improved by 275 bps from 1 year ago

What is ROE (FY)?

Strong EPS growth and above median growth of market

The company delivered strong EPS growth of 46.35% for 12-month ended 31 Mar 2026 and the growth was 41.14 percentage points higher than median growth of market

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.72 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.08 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 81.4 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

81.4 / 100

Negative

Expensive and at a premium to market median P/E

PE TTM of 44.64 indicates that the stock is expensive on a standalone basis and is at a 94.26% premium to market median P/E

What is P/E Ratio?

Median: 22.98

Value 44.64

-4046.8170640.8

Low but stable operating margin

The company reported low operating margin of 4.71% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 83 bps from 1 year ago

What is Operating profit margin?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate revenue growth and in line with median growth of market

The company delivered moderate revenue growth of 12.33% for 12-month ended 31 Mar 2026 and the growth was 1.92 percentage points higher than median growth of market

What is Sales growth (1Y)?

Median: 10.41

Value 12.33

-7635.64179204992

Financial Snapshot

See detailed analysis

Multi-year trends for Medplus Health Services Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Medplus Health Services Ltd. Shareholding Pattern

Quarterly breakdown of Medplus Health Services Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2014	Sep 2015	Sep 2016	Dec 2017	Oct 2018	Sep 2019	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	50.08	18.71	18.71	18.71	88.74	93.49	40.43	40.43	40.43	40.43	40.43	40.43	40.43	40.41	40.45	40.39	40.39	40.39	40.39	40.34	40.32	40.29	40.29	40.22
Indian Promoter	0.68	18.71	18.71	18.71	88.74	93.49	40.43	40.43	40.43	40.43	40.43	40.43	40.43	40.41	40.45	40.39	40.39	40.39	40.39	40.34	40.32	40.29	40.29	40.22
Foreign Promoter	49.40	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	31.14	32.21	32.63	32.58	32.72	32.65	33.00	37.86	38.15	37.41	37.02	42.69	40.88	41.80	42.45	43.05	43.40	43.35
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	11.54	11.99	12.29	12.17	11.94	12.21	12.41	15.60	15.40	12.87	12.25	18.08	21.51	21.59	21.47	21.48	21.48	22.60
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.00	0.00	2.14	2.25	1.45	1.20	1.02	0.89	0.92	1.12	3.03	2.47	2.26	2.17	2.24	2.29	2.37
Govt	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	3.42	2.97	3.15	3.74	3.94	4.48	4.87	12.37	12.96	14.94	14.85	14.72	15.23	15.61	16.43	16.53	16.83	15.53
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	16.11	17.26	17.19	14.53	14.58	14.50	14.52	8.88	8.90	8.68	8.80	6.87	1.68	2.34	2.39	2.79	2.81	2.85
Non-Institution	49.92	81.29	81.29	81.29	11.26	6.51	28.43	27.36	26.94	26.99	26.85	26.93	26.57	21.74	21.40	22.20	22.59	16.92	18.73	17.86	17.22	16.65	16.30	16.44
Bodies Corporate	0.00	49.68	49.68	0.59	3.46	3.46	2.75	2.28	2.11	1.84	1.84	1.94	2.03	2.33	2.24	1.89	2.01	3.11	3.75	3.11	3.18	3.03	3.00	3.22
Others (incl. Retail) No. of shareholders	49.92 0	31.61 0	31.61 0	80.70 28	7.80 0	3.05 0	25.68 1,02,274	25.08 82,430	24.83 76,983	25.15 76,831	25.01 74,558	24.99 73,306	24.54 69,783	19.41 66,127	19.16 65,764	20.31 74,416	20.58 76,295	13.81 86,504	14.98 83,007	14.75 82,538	14.04 80,825	13.62 77,325	13.30 78,049	13.22 76,142

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Microcap 250	0.78%	21 / 250
2	Nifty Total Market	0.03%	390 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Medplus Health Services Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Lone Furrow Investments Private Limited Promoter	December-2023	Market Purchase (Acquisition) 15th Dec 2023	14.44 %	₹ 739.85	9.12 k	₹ 67.50 lac
Lone Furrow Investments Private Limited Promoter	December-2023	Market Purchase (Acquisition) 15th Dec 2023	14.45 %	₹ 735.00	4.76 k	₹ 35.02 lac
Madhavan Ganesan Connected Person	December-2021	Market Purchase (Acquisition) 24th Dec 2021	0.00 %	₹ 1,100.00	5.00 k	₹ 55.00 lac

No corporate action data available.

Company Profile

Overview of Medplus Health Services Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer go...

Key personnel

Mr. Sujit Kumar Mahato

Chief Financial Officer

Subrahmanyam Sharma Tatapudi

Chief Technology Officer

Mr. Manoj Kumar Srivastava

Head - Corporate Secretarial, Compliance Officer, Company Secretary

Mr. Kandasamy Vairaperumal

Head of Supply Chain

Mr. Gangadi Madhukar ReddyD

Executive Chairman of the Board, Chief Executive Officer, Managing Director

Dr. Cherukupalli Bhaskar ReddyD

Chief Operating Officer, Whole-time Director

Mr. Thyagarajan MuralidharanD

Non-Executive Independent Director

Ms. Aparna SurabhiD

Non-Executive Independent Director

View all

Incorporated on

30 Nov 2006

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

23 Dec 2021

Free Float

7,00,44,965

Website

https://www.medplusindia.com/

Phone no.

+914067006700

Address

H. NO: 11-6-56, SURVEY NO: 257 & 258/1 OPP: IDPL RAILWAY SIDING ROAD,MOOSAPET, KUKATPALLY,, , 500037, India

Frequently Asked Questions

What is the current share price of Medplus Health Services Ltd.?

The current share price of Medplus Health Services Ltd. is ₹ 816.20 as of 8 Jul 2026.

What is the market capitalisation of Medplus Health Services Ltd.?

The market capitalisation of Medplus Health Services Ltd. stands at ₹ 9,805.58 Cr.

What is the PE ratio of Medplus Health Services Ltd.?

The Price-to-Earnings (PE) ratio of Medplus Health Services Ltd. is 44.64 as of the latest trailing twelve months data.

What is the ROE and ROCE of Medplus Health Services Ltd.?

Medplus Health Services Ltd. has a Return on Equity (ROE) of 11.82% and a Return on Capital Employed (ROCE) of 10.37% as per the latest financial reports.

What is the 52-week high and low of Medplus Health Services Ltd.?

The 52-week high of Medplus Health Services Ltd. is - and the 52-week low is -.

What is the dividend yield of Medplus Health Services Ltd.?

The dividend yield of Medplus Health Services Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Medplus Health Services Ltd.?

Foreign Institutional Investors (FII) hold 15.53%, Domestic Institutional Investors (DII) hold 24.97% and retail/public investors hold 13.22% of Medplus Health Services Ltd. shares.

What sector does Medplus Health Services Ltd. belong to?

Medplus Health Services Ltd. operates in the Consumer Services sector. 100% of analysts have a Buy or Strong Buy rating on Medplus Health Services Ltd. with a consensus target price of ₹ 1,150.00, implying 40.9% upside from current levels.

What is the beta of Medplus Health Services Ltd.?

The beta of Medplus Health Services Ltd. is 0.52, indicating its price volatility relative to the broader market. Over the past 1 year, Medplus Health Services Ltd. has delivered an absolute return of -9.76%.

What is the RSI of Medplus Health Services Ltd.?

The 14-day Relative Strength Index (RSI) of Medplus Health Services Ltd. is 38.15, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Medplus Health Services Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Medplus Health Services Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis

Holdings and Presence